| Disease | 25 PATIENTS WITH UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER WERE TREATED IN THIS PHASE 2 STUDY. PATIENTS WERE GIVEN TAXOL IN DOSES OF 200 MG/SQ. M OVER 24 HOURS AND REPEATED EVERY 3 WEEKS FOR UP TO A MAXIMUM OF 9 COURSES AND A MINUMUM OF 2.
THE OVERALL RESPONSE RATE WAS 24% WITH 1 COMPLETE RESPONSE AND 5 PARTIAL REPONSES. GRANULOCYTOPENIA WAS THE DOSE LIMITING TOXICITY. OTHER TOXICITES INCLUDED NEUTROPENIC FEVER, NEUTROPENIC SEPSIS WITH HYPOTENSION, ANEMIA, THROMBOCYTOPENIA,
FATIGUE, DIARRHEA, ALOPECIA, NAUSEA, EDEMA, DYSPNEA, HEADACHE AND ANOREXIA. |